Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IL4C
|
|||
| Former ID |
DIB014930
|
|||
| Drug Name |
TgDCC-E1A
|
|||
| Synonyms |
E1A tumor supressor gene product, Targeted Genetics; RGG-0853; DC-cholesterol (E1A); E1A/DC-cholesterol liposomes, Targeted Genetics; Gene therapy (cancer), Targeted Genetics/MD Anderson
Click to Show/Hide
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 2 | [1] | |
| Company |
Targeted Genetics Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02157870) A Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.